Clinical Trials in North Carolina

Showing 5861-5880 of 15,496 trials

A Study of Mirikizumab in Participants With Plaque Psoriasis

NCT03718884

This study is known as a "drug interaction study." The purpose is to learn how commonly used drugs or substances (midazolam, warfarin, dextromethorphan, omeprazole, and caffeine) and their breakdown products get into the bloodstream after taking a "cocktail" (combination) of them before and after multiple doses of mirikizumab. The study will last about 23 weeks for each participant. Screening must be completed within 4 weeks prior to study start.

Psoriasis

Eli Lilly and Company29 participantsStarted Oct 2018

Anaheim, California, United States • DeLand, Florida, United States • High Point, North Carolina, United States

UNKNOWNPhase 254 miles

Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

NCT04296864

This is a multi-center, double-masked, randomized, placebo-controlled, parallel-group, efficacy, safety, and tolerability study evaluating the efficacy of Dupilumab in the treatment of signs and symptoms of atopic keratoconjunctivitis (AKC).

Atopic Keratoconjunctivitis

Andover Eye Associates42 participantsStarted Feb 2020

Los Angeles, California, United States • Littleton, Colorado, United States • Hollywood, Florida, United States +17 more locations

A Study of Mirikizumab in Participants With Plaque Psoriasis

Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)

Find Trials by Condition in North Carolina

Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain

Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis

V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)

CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory CLL

EPI-743 for Mitochondrial Respiratory Chain Diseases

Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee

Incorporating Supersaturated Oxygen in Shock

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age

A Study to Assess Long-Term Safety of the CyPass Micro-Stent in Patients Completing the COMPASS Trial

A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia

A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Study to Compare Exposure of TA Following Administration of Either FX006 or TAcs in Patients With Bilateral Knee OA

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma

Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis